£27.5M
The Series B round was led by Lakestar with backing from institutional investors and venture funds to support team growth and product expansion.
AccuRx
AccuRx develops clinical software to combat anti-microbial resistance.
£27.9MTotal raised
AccuRx builds software designed to assist doctors in reducing inappropriate antibiotic prescriptions.
Categories
Founders
JH
Investors
Funding history
£355K
The funding round included backing from Anvil Partners and other business angels.